June 17, 2026 · Form 4 insider transaction
Dennis Phillip Andrew sold 10,302 shares of NovaBridge Biosciences at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.; Reported securities represent ADSs.; On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month.; The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.